CRP levels have also been tied to the odds of PCa development in patients exhibiting high levels of PSA, while also related to a greater chance of biochemical recurrence after undergoing curative treatment for localized PCa and to worse OS in patients with advanced disease (25, 39). The gene discussed is CRP; the disease is posterior cortical atrophy.